Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Current Leases (2019 - 2025)

Fortress Biotech (FBIO) has 7 years of Current Leases data on record, last reported at $2.1 million in Q3 2025.

  • For Q3 2025, Current Leases fell 15.31% year-over-year to $2.1 million; the TTM value through Sep 2025 reached $2.1 million, down 15.31%, while the annual FY2024 figure was $2.6 million, 3.96% up from the prior year.
  • Current Leases reached $2.1 million in Q3 2025 per FBIO's latest filing, down from $2.1 million in the prior quarter.
  • Across five years, Current Leases topped out at $2.6 million in Q4 2024 and bottomed at $1.8 million in Q1 2021.
  • Average Current Leases over 5 years is $2.3 million, with a median of $2.3 million recorded in 2022.
  • Peak YoY movement for Current Leases: increased 20.62% in 2021, then fell 16.99% in 2025.
  • A 5-year view of Current Leases shows it stood at $2.1 million in 2021, then rose by 16.3% to $2.4 million in 2022, then grew by 3.11% to $2.5 million in 2023, then increased by 3.96% to $2.6 million in 2024, then fell by 18.83% to $2.1 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Leases were $2.1 million in Q3 2025, $2.1 million in Q2 2025, and $2.2 million in Q1 2025.